COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 929: Articles 9281-9290  | Next

Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms
Woodcock, R. A., Bartels, L. J.
10.1101/2022.02.23.22271144 — Posted: 2022-02-24
SARS-CoV-2 RNA wastewater settled solids surveillance frequency and impact on predicted COVID-19 incidence using a distributed lag model
Schoen, M., Wolfe, M., Li, L., Duong, D., White, B., Hughes, B., Boehm, A.
10.1101/2022.02.21.22270864 — Posted: 2022-02-24
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) Network study
Sadarangani, M., Soe, P., Shulha, H., Valiquette, L., Vanderkooi, O. G., Kellner, J. D., Muller, M. P., Top, K. A., Isenor, J. E., McGeer, A., Irvine, M. A., De Serres, G., Marty, K., Bettinger, J. A., for the Canadian Immunization Research Network
10.1101/2022.02.22.22271358 — Posted: 2022-02-24
Impact of key meteorological parameters on the spread of COVID-19 in Mumbai: Correlation and Regression Analysis
Shetty, S., Gawade, A., Deolekar, S., Patil, V., Pandharkar, R., Salunkhe, U.
10.1101/2022.02.22.22271376 — Posted: 2022-02-24
Three-month follow-up of heterologous vs homologous third vaccination in kidney transplant recipients
Heinzel, A., Schrezenmeier, E., Regele, F., Raab, L., Eder, M., Aigner, C., Jabbour, R., Aschauer, C., Stefanski, A.-L., Doerner, T., Budde, K., Reindl-Schwaighofer, R., Oberbauer, R.
10.1101/2022.02.22.22270838 — Posted: 2022-02-24
Gestational SARS-CoV-2 infection is associated with placental expression of immune and trophoblast genes
Lesseur, C., Jessel, R. H., Ohrn, S., Ma, Y., Li, Q., Dekio, F., Brody, R. I., Wetmur, J. G., Gigase, F. A. J., Lieber, M., Lieb, W., Lynch, J., Afzal, O., Ibroci, E., Rommel, A.-S., Janevic, T., Stone, J., Howell, E. A., Galang, R. R., Dolan, S. M., Bergink, V., De Witte, L. D., Chen, J.
10.1101/2022.02.22.22271359 — Posted: 2022-02-24
SARS-CoV-2 Infection Breakthrough among the non-vaccinated and vaccinated: a Real World Evidence study based on Big Data
Perrella, A., BIsogno, M., D'Argenzio, A., Trama, U., Coscioni, E., Orlando, V.
10.1101/2022.02.22.21266830 — Posted: 2022-02-24
SARS-CoV-2 seroprevalence, vaccination, and hesitancy in agricultural workers in Guatemala
Calvimontes, D. M., Krisher, L., Cruz-Aguilar, A., Pilloni-Alessio, D., Crisostomo-Cal, L. E., Castaneda-Sosa, E. A., Butler-Dawson, J., Olson, D., Newman, L. S., Asturias, E. J.
10.1101/2022.02.22.22270907 — Posted: 2022-02-24
Avoiding false positive SARS-CoV-2 rapid antigen test results with point-of-care molecular testing on residual test buffer
LeBlanc, J. J., McCracken, G. R., Goodall, B., Hatchette, T. F., Barrett, L., Ross, J., Davidson, R. J., Patriquin, G.
10.1101/2022.02.18.22271189 — Posted: 2022-02-24
Abdominal Imaging Associates Body Composition with COVID-19 Severity
Basty, N., Sorokin, E. P., Thanaj, M., Srinivasan, R., Whitcher, B., Bell, J. D., Cule, M., Thomas, E. L.
10.1101/2022.02.22.22270091 — Posted: 2022-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).